Spain: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Spain

The Spanish market for other medicaments for therapeutic or prophylactic uses plummeted to $X in 2022, which is down by X% against the previous year. Overall, consumption, however, continues to indicate strong growth. As a result, consumption attained the peak level of $X. From 2020 to 2022, the growth of the market failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Spain

In value terms, production of other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022 estimated in export price. In general, production saw a relatively flat trend pattern. The pace of growth appeared the most rapid in 2021 with an increase of X% against the previous year. Over the period under review, production of reached the peak level at $X in 2012; however, from 2013 to 2022, production stood at a somewhat lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Spain

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the second year in a row after two years of growth. In general, exports recorded a slight downturn. The growth pace was the most rapid in 2017 with an increase of X%. As a result, the exports attained the peak of X tons. From 2018 to 2022, the growth of the exports of failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses rose modestly to $X in 2022. Overall, total exports indicated a modest increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports decreased by X% against 2020 indices. The growth pace was the most rapid in 2013 when exports increased by X%. Over the period under review, the exports of hit record highs at $X in 2017; however, from 2018 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Germany (X tons), Italy (X tons) and France (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Spain, together accounting for X% of total exports. The Netherlands, Romania, Sweden, Denmark, the Czech Republic, Portugal, Poland, the United States, Hungary and Ireland lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Romania (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), Italy ($X) and France ($X) appeared to be the largest markets for other medicaments for therapeutic or prophylactic uses exported from Spain worldwide, together comprising X% of total exports. The Netherlands, Poland, Sweden, the Czech Republic, Portugal, Denmark, Ireland, the United States, Romania and Hungary lagged somewhat behind, together accounting for a further X%.

Among the main countries of destination, Ireland, with a CAGR of X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, rising by X% against the previous year. Overall, export price indicated a perceptible expansion from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, export price for other medicaments for therapeutic or prophylactic uses increased by X% against 2019 indices. The most prominent rate of growth was recorded in 2014 when the average export price increased by X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2015 to 2022, the average export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Ireland ($X per ton), while the average price for exports to Romania ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Hungary (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Spain

In 2022, the amount of other medicaments for therapeutic or prophylactic uses imported into Spain skyrocketed to X tons, surging by X% compared with the year before. Overall, imports continue to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2020 with an increase of X% against the previous year. Imports peaked at X tons in 2013; however, from 2014 to 2022, imports failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. In general, imports enjoyed strong growth. The pace of growth was the most pronounced in 2018 with an increase of X% against the previous year. Imports peaked in 2022 and are likely to continue growth in the near future.

Imports by Country

In 2022, Switzerland (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Spain, accounting for a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Switzerland exceeded the figures recorded by the second-largest supplier, Germany (X tons), threefold. The third position in this ranking was held by China (X tons), with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Switzerland amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and China (X% per year).

In value terms, Switzerland ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Spain, comprising X% of total imports. The second position in the ranking was held by Germany ($X), with an X% share of total imports. It was followed by Croatia, with a X% share.

From 2012 to 2022, the average annual growth rate of value from Switzerland amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and Croatia (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, with an increase of X% against the previous year. In general, the import price saw resilient growth. The growth pace was the most rapid in 2018 when the average import price increased by X% against the previous year. The import price peaked at $X per ton in 2019; however, from 2020 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Italy ($X per ton), while the price for the UK ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :